Teva starts building new plant in Hungary

Teva Pharmaceutical Industries has begun building a new €65 million plant at its premises in Godollo near Budapest, Hungary. Its existing plant there generated revenues of more than Ft100 billion ($520.6 million) in 2008.

More from Anticancer

More from Therapeutic Category